King's College London

• Predicting Progression Free Survival after Systemic Therapy in Advanced Head and Neck Cancer: Bayesian regression and Model development

  Barber, P. R., Mustapha, R., Flores-Borja, F., Alfano, G., Ng, K., Weitsman, G., Dolcetti, L., Mohamed, A., Wong, F., Vicencio Bustamante, J., Galazi, M., Opzoomer, J., Arnold, J., Thavaraj, S., Kordasti, S., Doyle, J., Greenberg, J., Dillon, M., Harrington, K. J., Forster, M., & 2 othersCoolen, A. CC. & Ng, T., 23 Dec 2022, (E-pub ahead of print) In: eLife. In press

  Research output: Contribution to journal › Article › peer-review

• The microbiota and radiotherapy for head and neck cancer: What should clinical oncologists know?

  Reis Ferreira, M., Pasto, A., Ng, T., Patel, V., Guerrero Urbano, T., Sears, C. & Wade, W., Sep 2022, In: Cancer Treatment Reviews. 109, 102442.

  Research output: Contribution to journal › Review article › peer-review

• HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models

  Gómez, V., Galazi, M., Weitsman, G., Monypenny, J., Al-Salemee, F., Barber, P. R., Ng, K., Beatson, R., Szokol, B., Orfi, L., Mullen, G., Vanhaesebroeck, B., Chowdhury, S., Leung, H. Y. & Ng, T., 1 Apr 2022, In: Molecular Cancer Therapeutics. 21, 4, p. 667-676 10 p.

  Research output: Contribution to journal › Article › peer-review

• Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans

  Vicencio Bustamante, J., Evans, R., Green, R., An, Z., Deng, J., Treacy, C., Mustapha, R., Monypenny of Pitmilly, J., Costoya, C., Lawler, K., Ng, K., Desouza, K., Coban, O., Gomez, V., Clancy, J., Chen, SH., Chalk, A., Wong, F., Gordon, P., Savage, C., & 20 othersGomes, C., Pan, T., Alfano, G., Dolcetti, L., Chan, J. N. E., Florez-Borja, F., Barber, P., Weitsman, G., Sosnowska, D., Capone, E., Iacobelli, S., Hochhauser, D., Hartley, J., Parsons, M., Arnold, J., Ameer-Beg, S., Quezada, S. A., Yarden, Y., Sala, G. & Ng, T., 28 Mar 2022, In: Cell Death & Disease. 13, 3, 274 .

  Research output: Contribution to journal › Article › peer-review

View all (145) »